Pathomechanisms of Vascular Depression in Older Adults

Kurt A Jellinger1

  • 1Institute of Clinical Neurobiology, Alberichgasse 5/13, 1150 Vienna, Austria.

Insights

Late-life depression (LLD) is complex, with vascular and metabolic factors contributing significantly to its development and distinct characteristics. Understanding these factors is crucial for effective prevention and treatment strategies beyond standard antidepressants.

Area of Science:

  • Geriatric Psychiatry
  • Neuroscience
  • Vascular Biology

Background:

  • Late-life depression (LLD) is a complex mood disorder in older adults, often co-occurring with physical illnesses and leading to disability and mortality.
  • The precise risk factors for LLD remain unclear, and its underlying mechanisms differ from early-onset depression.
  • The interplay between depression and age-related diseases suggests shared pathogenic pathways.

Purpose of the Study:

  • To explore the contributing factors and pathogenic mechanisms of late-life depression (LLD).
  • To discuss the "vascular depression" hypothesis and its implications.
  • To highlight potential targets for LLD prevention and treatment.

Main Methods:

  • Review of evidence linking vascular mechanisms (cerebral small vessel disease, endothelial dysfunction) and metabolic factors (diabetes, inflammation) to LLD.
  • Discussion of the "vascular depression" hypothesis, emphasizing cerebrovascular disease and stroke.
  • Consideration of neurodegenerative and neuroimmune factors in LLD pathogenesis.

Main Results:

  • Vascular mechanisms, including cerebral small vessel disease and metabolic risk factors, are implicated in LLD development by causing brain lesions.
  • The "vascular depression" hypothesis links cerebrovascular disease to geriatric depression, characterized by cognitive deficits and reduced white matter integrity.
  • Vascular depression shows poorer response to antidepressants compared to major depressive disorder without vascular risk factors.

Conclusions:

  • Vascular and metabolic factors are key contributors to LLD, influencing its presentation and treatment response.
  • LLD may exhibit modest response to antidepressants, suggesting a need for targeted interventions.
  • Vascular and metabolic pathways offer promising targets for LLD prevention and treatment, requiring further research and clinical validation.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
14
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
301
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
3
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.8K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
9
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
12